Jun11165
Jun11165 is a SARS-CoV-2 PLpro inhibitor (IC50 ≤ 0.6 μM), which inhibits SARS-CoV-2 with an EC50 value of ≤ 6 μM. Jun11165 can be used in the research of viral infections[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/jun11165.html
Solubility
10 mM in DMSO
Smiles
C[C@@H](NC(C1=CC(OCCN)=CC=C1C)=O)C2=CC(C3=CSC=C3)=CC=C2
Molecular Formula
C22H24N2O2S
Molecular Weight
380.50
References & Citations
[1]Jadhav P, et al. Structure-based design of SARS-CoV-2 papain-like protease inhibitors. Eur J Med Chem. 2023 Dec 5;264:116011.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15172663 1 Vial
Lentiviral mouse Cds2 shRNA (UAS) - Lentiviral mouse Cds2 shRNA (UAS) plasmid
Ask
View Details 
329300-01 50 µg
SphK2, phosphorylated (T614) (SPHK2, Sphingosine kinase 2, SK 2, SPK 2)
Ask
View Details 329300-02 100 µg
SphK2, phosphorylated (T614) (SPHK2, Sphingosine kinase 2, SK 2, SPK 2)
Ask
View Details 
42080121 3x 1.0µg DNA
RPS12P6 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details